Willow Biosciences reported record Q3 2024 revenue of $1.7 million and announced a new partnership in the biopesticides sector expected to generate over $2 million in its first year. The company also closed a $1.6 million financing round, signed a royalty agreement with Kalsec, and increased its 2024 revenue guidance to over $4.5 million.